Related Experiment Video
Updated: Jul 23, 2025

06:52
Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
9.8K
Financial Health of People Living With Dementia and Their Informal Care Partners: Protocol for a Mixed Methods Study
Eli Robert Boone1,2, Heiley Tai3, Ali Raich3
1Duke-Margolis Center for Health Policy, Durham, NC, United States.
JMIR Research Protocols
|July 11, 2023
Summary
This study addresses financial toxicity in people with dementia and their care partners. Findings will inform strategies to improve care costs and support for this vulnerable population.
Area of Science:
- Gerontology
- Health Economics
- Public Health
Background:
- Financial toxicity, or financial strain, significantly impacts individuals with chronic conditions and their care partners.
- Populations with health disparities, such as those with dementia, experience exacerbated financial toxicity due to systemic inequities.
- Existing research on financial toxicity primarily focuses on cancer patients, with limited data on dementia populations.
Purpose of the Study:
- To adapt a survey for assessing financial toxicity in people living with dementia and their care partners.
- To characterize the extent and components of financial toxicity within this population.
- To amplify the voices and experiences of individuals with dementia and their care partners regarding financial toxicity through participatory methods.
Main Methods:
- A mixed-methods approach combining adapted validated instruments and photovoice.
- Development of a specialized financial toxicity survey for dementia dyads.
- Quantitative analysis of survey data from 100 dyads using descriptive statistics and regression models.
- Qualitative data collection through photovoice, integrating with quantitative findings via the pillar integration process.
Main Results:
- Study is ongoing; quantitative and qualitative results are anticipated by December 2023.
- The integrated findings will establish a comprehensive baseline understanding of financial toxicity in dementia care.
- Anticipated results will provide critical insights into the lived experiences of financial toxicity.
Conclusions:
- This study is among the first to investigate financial toxicity in the context of dementia care.
- Findings will guide the development of interventions to mitigate the financial burden of dementia care.
- The research protocol can serve as a model for studying financial toxicity in other chronic disease populations.
Related Concept Videos
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
Documentation in Long-Term and Home Healthcare Setting
931
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
931
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160

